Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07023835 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis

Study acronym: UNITE-ALS
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial sites expanded: 17 → 49 locationsv6
  2. Enrollment reopened
    • Study sites revised (17)
    v5
  3. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 17 of 17 sites
    v4
  4. Study sites: 15 to 17v3
  5. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 15
    • Start date changed from estimate of Sep 2025 to Sep 17, 2025
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Zydus Therapeutics Inc.
8 trials monitored
See 2 trials at risk
ALS
398 trials monitored
See 21 trials at risk
Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis
Trial Details
NCT Number NCT07023835
Lead Sponsor Zydus Therapeutics Inc.
Conditions
(from sponsor)		 Amyotrophic Lateral Sclerosis (ALS)
Related terms Amyotrophic Lateral Sclerosis
Enrollment 240 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov